{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:35:53Z","timestamp":1779903353163,"version":"3.53.1"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-15-0815","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T17:07:25Z","timestamp":1450976845000},"page":"426-434","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients"],"prefix":"10.1253","volume":"80","author":[{"given":"Norihisa","family":"Toh","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kansai Electric Power Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kihara Cardiovascular Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuomi","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Sakurabashi Watanabe Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Heart Center, Tokyo Bay Urayasu\/Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nishinomiya Watanabe Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Effect of ARB\/Diuretics on Diastolic Function in Patients with Hypertension 2 (EDEN2) trial investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. <i>N Engl J Med<\/i> 1992; 327: 998\u20131008.","DOI":"10.1056\/NEJM199210013271406"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. <i>JAMA<\/i> 1996; 275: 1557\u20131562.","DOI":"10.1001\/jama.1996.03530440037034"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. <i>N Engl J Med<\/i> 2006; 355: 251\u2013259.","DOI":"10.1056\/NEJMoa052256"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. <i>Lancet<\/i> 2007; 369: 2079\u20132087.","DOI":"10.1016\/S0140-6736(07)60980-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, Oparil S, et al. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. <i>Hypertension<\/i> 2010; 55: 241\u2013248.","DOI":"10.1161\/HYPERTENSIONAHA.109.138529"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Elliott WJ. Is fixed combination therapy appropriate for initial hypertension treatment? <i>Curr Hypertens Rep<\/i> 2002; 4: 278\u2013285.","DOI":"10.1007\/s11906-996-0005-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. <i>J Hypertens<\/i> 2014; 32: 3\u201315.","DOI":"10.1097\/HJH.0000000000000065"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). <i>Hypertens Res<\/i> 2009; 32: 3\u2013107.","DOI":"10.1038\/hr.2009.34"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito H, Ishii K, Kihara H, Kasayuki N, Nakamura F, Shimada K, et al. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. <i>Hypertens Res<\/i> 2012; 35: 93\u201399.","DOI":"10.1038\/hr.2011.169"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ito H, Ishii K, Iwakura K, Nakamura F, Nagano T, Takiuchi S. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: Multi-center study with echocardiography. <i>Hypertens Res<\/i> 2009; 32: 895\u2013900.","DOI":"10.1038\/hr.2009.119"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Paulus WJ, Tsch\u00f6pe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. <i>Eur Heart J<\/i> 2007; 28: 2539\u20132550.","DOI":"10.1093\/eurheartj\/ehm037"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Daimon M, Watanabe H, Abe Y, Hirata K, Hozumi T, Ishii K, et al. Normal values of echocardiographic parameters in relation to age in a healthy Japanese population: The JAMP study. <i>Circ J<\/i> 2008; 72: 1859\u20131866.","DOI":"10.1253\/circj.CJ-08-0171"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr<\/i> 2015; 28: 1\u201339.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. <i>J Hypertens<\/i> 2005; 23: 183\u2013191.","DOI":"10.1097\/00004872-200501000-00029"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, et al. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. <i>J Hypertens<\/i> 2005; 23: 393\u2013400.","DOI":"10.1097\/00004872-200502000-00022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nishikawa N, Masuyama T, Yamamoto K, Sakata Y, Mano T, Miwa T, et al. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. <i>J Am Coll Cardiol<\/i> 2001; 38: 1539\u20131545.","DOI":"10.1016\/S0735-1097(01)01548-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen CH, Nakayama M, Talbot M, Nevo E, Fetics B, Gerstenblith G, et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. <i>J Am Coll Cardiol<\/i> 1999; 33: 1602\u20131609.","DOI":"10.1016\/S0735-1097(99)00052-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Goda A, Masuyama T. Left ventricular hypertrophy as a target of treatment in patients with hypertension. <i>Circ J<\/i> 2014; 78: 2633\u20132634.","DOI":"10.1253\/circj.CJ-14-1049"},{"key":"19","unstructured":"19. Dahl\u00f6f B. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: A review. <i>J Hum Hypertens<\/i> 1995; 9(Suppl 5): S37\u2013S44."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Devereux RB, Dahl\u00f6f B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. <i>Circulation<\/i> 2004; 110: 1456\u20131462.","DOI":"10.1161\/01.CIR.0000141573.44737.5A"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sawa T, Sato Y, Matsuda M, Tanaka M, Miyazaki S, Furukawa Y, et al. Regression of electrocardiographic signs of left ventricular hypertrophy by combined treatment with thiazide diuretic and angiotensin-II receptor blocker. <i>Circ J<\/i> 2014; 78: 2719\u20132726.","DOI":"10.1253\/circj.CJ-14-0713"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients &gt; or = 65 years of age with well-preserved left ventricular systolic function. <i>Am J Cardiol<\/i> 2005; 96: 832\u2013836.","DOI":"10.1016\/j.amjcard.2005.05.031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Okura H, Kubo T, Asawa K, Toda I, Yoshiyama M, Yoshikawa J, et al. Elevated E\/E\u2019 predicts prognosis in congestive heart failure patients with preserved systolic function. <i>Circ J<\/i> 2009; 73: 86\u201391.","DOI":"10.1253\/circj.CJ-08-0457"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kwon BJ, Jang SW, Choi KY, Lee JB, Kim DB, Cho EJ, et al. Independent determinants for presence and degree of left ventricular systolic dyssynchrony in treatment-naive patients with hypertension. <i>J Hypertens<\/i> 2013; 31: 601\u2013609.","DOI":"10.1097\/HJH.0b013e32835d4acf"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Motoki H, Koyama J, Izawa A, Tomita T, Miyashita Y, Takahashi M, et al. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy. <i>Echocardiography<\/i> 2014; 31: 1230\u20131238.","DOI":"10.1111\/echo.12548"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. <i>N Engl J Med<\/i> 2008; 359: 2417\u20132428.","DOI":"10.1056\/NEJMoa0806182"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, et al. Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: A randomized, controlled trial. <i>J Hypertens<\/i> 2014; 32: 2054\u20132063.","DOI":"10.1097\/HJH.0000000000000281"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. <i>N Engl J Med<\/i> 2008; 358: 1547\u20131559.","DOI":"10.1056\/NEJMoa0801317"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bangalore S, Kumar S, Wetterslev J, Messerli FH. Angiotensin receptor blockers and risk of myocardial infarction: Meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. <i>BMJ<\/i> 2011; 342: d2234.","DOI":"10.1136\/bmj.d2234"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. <i>Am J Cardiol<\/i> 2012; 110: 383\u2013391.","DOI":"10.1016\/j.amjcard.2012.03.034"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mancia G, Parodi A, Merlino L, Corrao G. Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. <i>J Hypertens<\/i> 2011; 29: 1012\u20131018.","DOI":"10.1097\/HJH.0b013e32834550d0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Toh R, Ishida T, Nishimura K, Nonaka H, Inoue Y, Kitagawa Y, et al. Comparison of medium-dose losartan\/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: The Kobe-CONNECT Study. <i>Hypertens Res<\/i> 2012; 35: 1080\u20131086.","DOI":"10.1038\/hr.2012.110"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. L\u00f6ffler AI, Cappola TP, Fang J, Hetzel SJ, Kadlec A, Astor B, et al. Effect of renal function on prognosis in chronic heart failure. <i>Am J Cardiol<\/i> 2015; 115: 62\u201368.","DOI":"10.1016\/j.amjcard.2014.09.055"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, et al. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. <i>Am Heart J<\/i> 2012; 163: 407\u2013414.","DOI":"10.1016\/j.ahj.2011.12.003"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: The importance of change over time. <i>Circulation<\/i> 2007; 116: 249\u2013257.","DOI":"10.1161\/CIRCULATIONAHA.107.694562"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, et al; PREVEND study group. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. <i>Eur Heart J<\/i> 2012; 33: 2272\u20132281.","DOI":"10.1093\/eurheartj\/ehs163"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mukete BN, Rosendorff C. Effects of low-dose thiazide diuretics on fasting plasma glucose and serum potassium-a meta-analysis. <i>J Am Soc Hypertens<\/i> 2013; 7: 454\u2013466.","DOI":"10.1016\/j.jash.2013.05.004"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kohro T, Yamazaki T. Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design. <i>Hypertens Res<\/i> 2009; 32: 109\u2013114.","DOI":"10.1038\/hr.2008.26"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. <i>J Am Soc Echocardiogr<\/i> 2009; 22: 107\u2013133.","DOI":"10.1016\/j.echo.2008.11.023"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-0815\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:30:54Z","timestamp":1498257054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-0815\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0815","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}